Holen Sie sich die Stockscreener-App
2.00
3.38%
-0.07
Vorhandelsmarkt:
1.92
-0.08
-4.00%
Schlusskurs vom Vortag:
$2.07
Offen:
$1.99
24-Stunden-Volumen:
6.38M
Relative Volume:
0.79
Marktkapitalisierung:
$18.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.07M
KGV:
-0.143
EPS:
-13.99
Netto-Cashflow:
$-12.56M
1W Leistung:
+20.48%
1M Leistung:
+25.00%
6M Leistung:
+152.40%
1J Leistung:
-27.80%
1-Tages-Spanne:
$1.765
$2.03
1-Wochen-Bereich:
$1.64
$2.14
52-Wochen-Spanne:
$0.53
$3.30
Palisade Bio Inc Stock (PALI) Company Profile
Firmenname
Palisade Bio Inc
Sektor
Branche
Telefon
(858) 704-4900
Adresse
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Vergleichen Sie PALI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
2.00 | 289.31M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Palisade Bio Inc Aktie (PALI) Neueste Nachrichten
Using RSI to spot recovery in Palisade Bio Inc.Index Update & Weekly Stock Performance Updates - newser.com
Will Palisade Bio Inc. stock deliver better than expected guidanceEarnings Beat & Accurate Technical Buy Alerts - newser.com
Palisade Bio Inc. recovery potential after sell offJuly 2025 Setups & Fast Entry Momentum Trade Alerts - newser.com
Automated trading signals detected on Palisade Bio Inc.Bull Run & Weekly High Momentum Picks - newser.com
Why Palisade Bio Inc. stock remains resilientEarnings Trend Report & Capital Efficient Trade Techniques - newser.com
Is Palisade Bio Inc. stock attractive for retirement portfoliosPortfolio Value Report & Safe Swing Trade Setups - newser.com
Why Palisade Bio Inc. stock could be next big winnerPortfolio Value Summary & Low Risk Entry Point Tips - newser.com
What sentiment indicators say about Palisade Bio Inc. stockExit Point & Pattern Based Trade Signal System - newser.com
Palisade Bio Inc. stock momentum explainedInsider Buying & AI Enhanced Trading Signals - newser.com
Is Palisade Bio Inc. stock trading near support levelsMarket Trend Report & Trade Opportunity Analysis - newser.com
What MACD and RSI say about Palisade Bio Inc.Weekly Trend Summary & High Return Trade Opportunity Guides - newser.com
How to track smart money flows in Palisade Bio Inc.Trade Exit Summary & Weekly High Potential Alerts - newser.com
Why Palisade Bio Inc. (7NS0) stock could outperform next year2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com
Using data filters to optimize entry into Palisade Bio Inc.2025 Dividend Review & Verified Entry Point Detection - newser.com
Will Palisade Bio Inc. stock benefit from AI adoptionShare Buyback & Detailed Earnings Play Alerts - newser.com
Should I hold or sell Palisade Bio Inc. stock in 2025Quarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
Can volume confirm reversal in Palisade Bio Inc.Volume Spike & Reliable Price Action Trade Plans - newser.com
Palisade Bio’s Unexpected Surge: Analyzing Recent Developments - StocksToTrade
Palisade Bio appoints Sharon Skare as VP of global clinical operations - Investing.com Australia
Forecasting Palisade Bio Inc. price range with options dataJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Palisade Bio Inc Stock Analysis and ForecastTrading Volume Surges & Access High Yield Alerts - earlytimes.in
Will Palisade Bio Inc. stock maintain momentum in 2025July 2025 Intraday Action & Community Consensus Trade Signals - fcp.pa.gov.br
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations - The Manila Times
Palisade Bio (NASDAQ: PALI) appoints Sharon Skare; IND planned H1 2026 for PALI-2108 - Stock Titan
Finanzdaten der Palisade Bio Inc-Aktie (PALI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):